CoSara starts TB clinical trials in India using Co-Diagnostics PCR tech
Go back to CoSara starts TB clinical trials in India using Co-Diagnostics PCR tech| (NASDAQ: CODX) | Delayed: 1.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.01 | 52 Week High | $ | |||
| Open | $1.01 | 52 Week Low | $ | |||
| Day High | $1.01 | P/E | N/A | |||
| Day Low | $1.01 | EPS | $ | |||
| Volume | 4,434 | |||||
